Clinical trials: PHA1A
PHA1A
Plasma and Intrapulmonary Concentrations Study of WCK 5222
This is a Phase 1, multiple dose, open-label pharmacokinetic study in healthy adult male and female subjects.
- Trial name
- NCT03630094
- Testing
- FEP-ZID
- Where
- United States
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- Wockhardt
PHA1A
A Study to Assess the Safety of SAB-176 to Prevent the Flu, Given IM in Healthy Adults Compared With Placebo
This study will evaluate the safety and tolerability of an intramuscular injection of SAB-176 intended for use as a pre/post prophylactic for influenza.
- Trial name
- SAB-176-103 (NCT06435936)
- Testing
- Single Ascending Dose of SAB-176
- Where
- United States
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- SAb Biotherapeutics, Inc.
PHA1A
A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.
This is a Phase I, Single-Center, Open-Label study evaluating the safety and pharmacokinetics of single doses of ZID-FEP and metronidazole alone or in combination utilizing a 3-period, crossover study design.
- Trial name
- NCT06806995
- Testing
- Zidebactam-Cefepime, Metronidazole, FEP-ZID
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Wockhardt
PHA1A
Tolerance, PK and PD Effects Study of TPN-672 in Chinese Healthy Volunteers
This is a single-site, randomized, double-blind, placebo-controlled, incremental phase I clinical trial to evaluate preliminarily the tolerance, pharmacokinetics and pharmacodynamic effects of TPN672 maleate in Chinese healthy…
- Trial name
- NCT03931668
- Testing
- TPN-672
- Where
- China
- Volunteers
- 62 people, healthy volunteers welcome
- Sponsor
- Shanghai Mental Health Center